Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ consortium longer duration nonclinical to clinical translational database.
Saved in:
| Title: | Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ consortium longer duration nonclinical to clinical translational database. |
|---|---|
| Authors: | Monticello TM; Translational Safety and Bioanalytical Analysis, Amgen, Thousand Oaks, CA 91320, United States of America., Potter DM; Independent Statistical Consultant, Bristol, RI 02809, United States of America., Huang Q; Boehringer Ingelheim, Ridgefield, CT, 06879, United States of America., Hart TK; GlaxoSmithKline, King of Prussia, PA, 19406, United States of America., Shuey D; Toxicology, Incyte Corporation, Wilmington, DE 19803, United States of America., Troth S; Nonclinical Drug Safety, Merck and Co., Inc., Rahway, NJ, 07065, United States of America., Vergis JM; IQ Consortium, Washington, DC, 20005, United States of America., Tassew N; Safety Assessment, Genentech, South San Francisco, CA, 92056, United States of America., Glascott P; Preclinical Safety, Sanofi, Bridgewater, NJ, 08807, United States of America. Electronic address: peter.glascott@sanofi.com. |
| Source: | Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Nov; Vol. 492, pp. 117087. Date of Electronic Publication: 2024 Sep 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0333 (Electronic) Linking ISSN: 0041008X NLM ISO Abbreviation: Toxicol Appl Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1096-0333 |
|---|---|
| DOI: | 10.1016/j.taap.2024.117087 |
